
Regulatory affairs in 2023: Key trends and changes
Dr Julie Warner is Vice President of Regulatory Affairs at global drug development consultancy, Boyds. In this article, she provides her expert insights into the key regulatory developments likely to shape the global drug development industry this year. Implementation of the EU Clinical Trials Regulation The way clinical trials (CTs)… Read More













